Have a personal or library account? Click to login
The fluctuation of free amino acids in serum during acute ischemic stroke Cover

The fluctuation of free amino acids in serum during acute ischemic stroke

Open Access
|Jan 2017

References

  1. 1. Brasse-Lagnel C. et al.: Glutamine stimulates argininosuccinate synthetase gene expression through cytosolic O-glycosylation of Sp1 in Caco-2 cells. J Biol Chem., 278, 52504, 2003.10.1074/jbc.M30675220014570901
  2. 2. Castillo J., Rodriguez I.: Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis., 17 Suppl 1, 7, 2004.10.1159/00007479114694276
  3. 3. Harston, George W J et al.: The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity. J Cereb Blood Flow Metab., 30, 1804, 2010.
  4. 4. Horecka A. et al.: Actylise treatment does not influence nitric oxide metabolites serum level. Pharmacol Rep, 2016.10.1016/j.pharep.2015.12.01026971035
  5. 5. Huang Y.F., Wang Y., Watford M.: Glutamine directly downregulates glutamine synthetase protein levels in mouse C2C12 skeletal muscle myotubes. J Nutr., 137, 1357, 2007.
  6. 6. Karna E., Szoka L., Palka J.A.: Captopril-dependent inhibition of collagen biosynthesis in cultured fibroblasts. Pharmazie., 65, 614, 2010.
  7. 7. Kimberly W.T. et al.: Metabolite profiling identifies a branched chain amino acid signature in acute cardioembolic stroke. Stroke., 44, 1389, 2013.10.1161/STROKEAHA.111.000397381608923520238
  8. 8. Kuklina E.V. et al.: Epidemiology and prevention of stroke: a worldwide perspective. Expert Rev Neurother., 12, 199, 2012.10.1586/ern.11.99447858922288675
  9. 9. Kurzepa J. et al.: Thrombolytic treatment decreases glutamate/GABA ratio in serum during acute ischaemic stroke: a pilot study. Neurol Res., 37, 934, 2015.10.1179/1743132815Y.000000004926005019
  10. 10. Miao Y., Liao J.K.: Potential serum biomarkers in the pathophysiological processes of stroke. Expert Rev Neurother., 14, 173, 2014.
  11. 11. Nagata C. et al.: Dietary intakes of glutamic Acid and glycine are associated with stroke mortality in Japanese adults. J Nutr., 145, 720, 2015.10.3945/jn.114.20129325833775
  12. 12. Newsholme P. et al.: New insights into amino acid metabolism, beta-cell function and diabetes. Clin Sci (Lond)., 108, 185, 2005.10.1042/CS2004029015544573
  13. 13. Phang J.M. et al.: Proline metabolism and cancer: emerging links to glutamine and collagen. Curr Opin Clin Nutr Metab Care., 18, 71, 2015.10.1097/MCO.0000000000000121425575925474014
  14. 14. Raman K., Pare G.: Of stroke and biomarkers: the elusive quest for a clinical biomarker panel. Clin Biochem., 46, 705, 2013.
  15. 15. Salemi G. et al.: Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke. Neurol Sci., 30, 361, 2009.
  16. 16. Skovierova H. et al.: Effect of homocysteine on survival of human glial cells. Physiol Res, 2015.10.33549/physiolres.93289725804098
  17. 17. Staszewski J. et al.: Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. J Stroke Cerebrovasc Dis., 20, 150, 2011.10.1016/j.jstrokecerebrovasdis.2009.11.01320621520
  18. 18. Szpetnar M., Pasternak K., Boguszewska A.: Branched chain amino acids (BCAAs) in heart diseases (ischaemic heart disease and myocardial infarction). Ann Univ Mariae Curie Sklodowska Med., 59, 91, 2004.
  19. 19. Takemoto Y.: Intracisternally injected L-proline activates hypothalamic supraoptic, but not paraventricular, vasopressin-expressing neurons in conscious rats. J Amino Acids., 2011, 230613, 2011.10.4061/2011/230613326803422312458
  20. 20. Tom A., Nair K.S.: Assessment of branched-chain amino Acid status and potential for biomarkers. J Nutr., 136, 324S-30S, 2006.10.1093/jn/136.1.324S16365107
  21. 21. Watford M.: Lowered concentrations of branched-chain amino acids result in impaired growth and neurological problems: insights from a branched-chain alpha-keto acid dehydrogenase complex kinase-deficient mouse model. Nutr Rev., 65, 167, 2007.10.1301/nr.2007.apr.167-172
  22. 22. Wong, Peter T H et al.: High plasma cyst(e)ine level may indicate poor clinical outcome in patients with acute stroke: possible involvement of hydrogen sulfide. J Neuropathol Exp Neurol., 65, 109, 2006.
  23. 23. Wu G.: Amino acids: metabolism, functions, and nutrition. Amino Acids., 37, 1, 2009.
  24. 24. Wu G. et al.: Arginine metabolism and nutrition in growth, health and disease. Amino Acids., 37, 153, 2009.10.1007/s00726-008-0210-y267711619030957
DOI: https://doi.org/10.1515/cipms-2016-0031 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 151 - 154
Submitted on: Mar 24, 2016
|
Accepted on: Jul 18, 2016
|
Published on: Jan 23, 2017
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Maria Szpetnar, Anna Hordyjewska, Iwona Malinowska, Piotr Golab, Jacek Kurzepa, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.